Target intelligence / Profile preview

ARHGEF9 intronic transcript 1 (non-protein coding) (ARHGEF9-IT1)

Target: ARHGEF9-IT1
Molecular classification: Long non-coding RNA (lncRNA), Non-protein-coding RNA

Overview

ARHGEF9 intronic transcript 1 is a long non-coding RNA transcribed from the intronic region of the ARHGEF9 gene. Unlike the ARHGEF9 protein-coding transcript, which encodes collybistin (a Rho GTPase exchange factor involved in neurological development and synaptic function[3][7]), ARHGEF9-IT1 does not code for a protein[1][5]. Long non-coding RNAs such as ARHGEF9-IT1 are known to influence cellular functions by interacting with DNA, RNA, and proteins, thereby impacting gene regulation, chromatin organization, and nuclear structure[4][6]. However, specific biological roles, disease associations, and drug interactions for ARHGEF9-IT1 are currently unclear. It is not considered a canonical therapeutic target (e.g. receptor, enzyme, transporter, ion channel, or transcription factor), although future research may clarify its functional relevance and potential roles in human disease.

Other names: ARHGEF9-IT1ARHGEF9 intronic transcript 1 (non-protein coding)ARHGEF9-IT1 RNA

Biological functions

Potential post-transcriptional regulation of gene expressionMay influence nuclear organization, epigenetic modifications, or chromatin structure typical for lncRNAs

Disease associations

Other (no direct evidence for involvement in specific diseases, but may be relevant due to regulatory functions of the parent gene, which is implicated in neurological disorders)

Beyond the preview

Go deeper on ARHGEF9 intronic transcript 1 (non-protein coding) (ARHGEF9-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARHGEF9 intronic transcript 1 (non-protein coding) (ARHGEF9-IT1).

Explore the full profile